What we are studying
This research study is being done to see if the investigational drug, Perampanel (E2007) (called, “Study Drug”) is safe, tolerable, and can help control seizure in children with epilepsy who are 1 month to less than 24 months of age and who are already taking seizure medications. The goal of this study is to determine the concentration of the study drug in your child’s blood over a period of time.